SC 13G Filing

Company

Celldex Therapeutics, Inc.

Filed

March 30, 2006

Accession Number

0001012975-06-000154

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →